Skip to main content
Joel Schuman, MD, Ophthalmology, Philadelphia, PA

JoelSSchumanMDFACS(He/Him)

Ophthalmology Philadelphia, PA

Anterior Segment Related, Cataract Related, Glaucoma Related

Kenneth L. Roper, MD Endowed Chair; Vice Chair for Research Innovation, Vickie and Jack Farber Vision Research Center; Co-Director, Glaucoma Service, Wills Eye Hospital; Professor, Department of Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University, Professor of Biomedical Engineering, Drexel School of Biomedical Engineering

Dr. Schuman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schuman's full profile

Already have an account?

  • Office

    840 Walnut Street
    Suite 1110
    Philadelphia, PA 19107
    Phone+1 215-928-3197
    Fax+1 215-928-0166

Summary

  • As of May 1, 2023, Joel S. Schuman, MD, FACS is Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation and Co-Director of the Glaucoma Service at Wills Eye Hospital. He is also Professor of Biomedical Engineering at Drexel University School of Biomedical Engineering, Science and Health Systems. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine 2016-2020, and was Vice Chair for Ophthalmology Research in the department 2020-2022. Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology at University of Pittsburgh and UPMC (2003-2016) and before that was at Tufts University where he was Residency Director (1991-1999), Glaucoma and Cataract Service Chief (1991-2003) and Vice Chair (2001-2003).

    Dr. Schuman and his colleagues were first to identify a molecular marker for human glaucoma, published in Nature Medicine in 2001. Continuously funded by the National Eye Institute as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 450 peer-reviewed scientific journal articles.

    In 2002 he received the Alcon Research Institute Award and the Lewis Rudin Glaucoma Prize and in 2012 the Carnegie Science Center Award as well as sharing the Champalimaud Award. In 2013 he received the AAO Lifetime Achievement Award. In 2014 he became a Gold Fellow of ARVO and received a Special Recognition Award from the AAO in 2015. In 2022 he received the USC Keck Roski Eye Institute Laureate Award and the Pittsburgh Eye and Ear Foundation Muse Award.

Education & Training

  • Massachusetts Eye and Ear Infirmary/Harvard Medical School
    Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Ophthalmology, 1988 - 1990
  • Medical College of Virginia
    Medical College of VirginiaResidency, Ophthalmology, 1985 - 1988
  • Icahn School of Medicine at Mount Sinai/Beth Israel
    Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1984 - 1985
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1984, MD
  • Columbia University
    Columbia UniversityB.A., Psychology, Cum Laude, 1977 - 1980
  • University of Pennsylvania
    University of PennsylvaniaNone, 1976 - 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - 2026
  • VA State Medical License
    VA State Medical License 1985 - 2026
  • MA State Medical License
    MA State Medical License 1988 - 2025
  • PA State Medical License
    PA State Medical License 2003 - 2024
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly
  • American Association of Physicians American Association of Physicians, 2016
  • America’s Top Doctors – The Best in American Medicine 2006-present
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Seeing the Hidden Lamina: Effects of Exsanguination on the Optic Nerve Head  
    Joel S Schuman, Matthew A Smith, Investigative Ophthalmology and Visual Science
  • Psychophysical Evaluation of Haptic Perception Under Augmentation by a Handheld Device  
    Wu B, Klatzky R, Lee R, Shivaprabhu V, Galeotti J, Siegel M, Schuman JS, Hollis R, Stetten G, Human Factors: The Journal of the Human Factors and Ergonomics Society., 1/26/2014
  • Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process  
    Springelkamp H, Höhn R, Mishra A, Hysi PG, Khor CC, Loomis SJ, Bailey JN, Gibson J, Thorleifsson G, Janssen SF, Luo X, Ramdas WD, Vithana E, Nongpiur ME, Montgomery GW..., Nat Commun, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Viability and Structural Integrity is Established in Vascularized Whole Eye Transplantation Model.
    Li Y, Komatsu C, Wang B, Kostereva N, Zhang W, Xiao B, Solari M, Kagemann, L, Wollstein G, Schuman JS, Gorantla V, Washington K, UPMC Plastic Surgery Resident Research Day, 1/27/2014
  • Measuring Effects of Intraocular and Intracranial Pressures on Optic Nerve Head Deformations.
    Wang Y, Schuman JS, Biomedical Engineering Society (BMES) Annual Meeting, San Antonio, TX, 1/22/2014
  • Machine classifer clustering of ocular structure.
    Nevins JE, Danks D, Wollstein G, Ishikawa H, Kagemann L, Sigal IA, Schuman JS, ARVO Annual Meeting, Seattle, WA, 1/9/2013
  • Join now to see all

Lectures

  • How to Use OCT in Deciding Whether or Not to Intervene in Glaucoma. 
    Maui, HI - 1/21/2015
  • Moderator – Glaucoma. 
    Maui, HI - 1/21/2015
  • Interpretation and Management of Glaucoma using OCT 
    Mexico City, Mexico - 1/21/2015
  • Join now to see all

Other

  • Welcome and Introduction: Spotlight on OCT. American Academy of Ophthalmology, Annual Meeting and Subspecialty Day, New Orleans, LA 
    Schuman JS, AAO Meetings On Demand
    1/1/2013
  • Three-dimensional spectral-domain optical coherence tomography data analysis for glaucoma detection. 
    Xu J, Ishikawa H, Wollstein G, Bilonick RA, Folio LS, Nadler Z, Kagemann L, Schuman JS
    1/1/2013
  • Glaucoma Progression: Structure and Function. 
    Kotowski J, Wollstein G, Ungar AK, Schuman JS, Focal Points, Clinical Modules for Ophthalmologist
    1/1/2013
  • Join now to see all

Press Mentions

  • Sprinting into the Field of Neuro-Ophthalmology from the Streets of Brooklyn
    Sprinting into the Field of Neuro-Ophthalmology from the Streets of BrooklynJuly 20th, 2020
  • This Is the Most Dangerous Thing You Can Do to Your Eyes
    This Is the Most Dangerous Thing You Can Do to Your EyesSeptember 14th, 2018
  • The Future of Ocular Imaging?
    The Future of Ocular Imaging?August 15th, 2018
  • Join now to see all

Grant Support

  • Novel Glaucoma Diagnostics For Structure And FunctionNational Eye Institute2000–2024
  • Novel Glaucoma Diagnostics For Structure And FunctionNational Eye Institute2003–2011
  • Novel Glaucoma Diagnostics For Structure And FunctionNational Eye Institute2000–2002
  • Measurement Of Nerve Fiber Layer Thickness In Normal AndNational Eye Institute1999
  • Optical Coherence Tomography--Novel Glaucoma DiagnosticNational Eye Institute1995–1998

Professional Memberships